AP NEWS

Europe Idiopathic Pulmonary Fibrosis Market and Competitive Landscape - 2018 - ResearchAndMarkets.com

November 15, 2018

DUBLIN--(BUSINESS WIRE)--Nov 15, 2018--The “Europe Idiopathic Pulmonary Fibrosis Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

Europe Idiopathic Pulmonary Fibrosis Market and Competitive Landscape - 2018 provides comprehensive insights into Idiopathic Pulmonary Fibrosis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Idiopathic Pulmonary Fibrosis market size and drug sales. This research also provides insights into Idiopathic Pulmonary Fibrosis epidemiology and late stage pipeline.

The research is classified into following sections - Idiopathic Pulmonary Fibrosis overview with definitions, symptoms, etiology, diagnosis, treatment options; Idiopathic Pulmonary Fibrosis pipeline insights covering late stage clinical trials pipeline; Idiopathic Pulmonary Fibrosis prevalence trends by countries; Idiopathic Pulmonary Fibrosis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Key Topics Covered

1. Idiopathic Pulmonary Fibrosis: Disease Overview

1.1. Idiopathic Pulmonary Fibrosis Symptoms

1.2. Idiopathic Pulmonary Fibrosis Etiology

1.3. Idiopathic Pulmonary Fibrosis Diagnosis

1.4. Idiopathic Pulmonary Fibrosis Treatment Options

2. Idiopathic Pulmonary Fibrosis Pipeline Insights

2.1. Idiopathic Pulmonary Fibrosis Phase 3 Clinical Trials

2.2. Idiopathic Pulmonary Fibrosis Phase 2 Clinical Trials

2.3. Idiopathic Pulmonary Fibrosis Phase 1 Clinical Trials

3. Idiopathic Pulmonary Fibrosis Epidemiology Analysis

4. Germany Idiopathic Pulmonary Fibrosis Market Insights

4.1. Marketed Products for Idiopathic Pulmonary Fibrosis in Germany

4.2. Germany Idiopathic Pulmonary Fibrosis Market Size & Forecast

4.3. Germany Idiopathic Pulmonary Fibrosis Product Sales Forecast

4.4. Germany Idiopathic Pulmonary Fibrosis Market Share Analysis

5. France Idiopathic Pulmonary Fibrosis Market Insights

5.1. Marketed Products for Idiopathic Pulmonary Fibrosis in France

5.2. France Idiopathic Pulmonary Fibrosis Market Size & Forecast

5.3. France Idiopathic Pulmonary Fibrosis Product Sales Forecast

5.4. France Idiopathic Pulmonary Fibrosis Market Share Analysis

6. Italy Idiopathic Pulmonary Fibrosis Market Insights

6.1. Marketed Products for Idiopathic Pulmonary Fibrosis in Italy

6.2. Italy Idiopathic Pulmonary Fibrosis Market Size & Forecast

6.3. Italy Idiopathic Pulmonary Fibrosis Product Sales Forecast

6.4. Italy Idiopathic Pulmonary Fibrosis Market Share Analysis

7. Spain Idiopathic Pulmonary Fibrosis Market Insights

7.1. Marketed Products for Idiopathic Pulmonary Fibrosis in Spain

7.2. Spain Idiopathic Pulmonary Fibrosis Market Size & Forecast

7.3. Spain Idiopathic Pulmonary Fibrosis Product Sales Forecast

7.4. Spain Idiopathic Pulmonary Fibrosis Market Share Analysis

8. UK Idiopathic Pulmonary Fibrosis Market Insights

8.1. Marketed Products for Idiopathic Pulmonary Fibrosis in UK

8.2. UK Idiopathic Pulmonary Fibrosis Market Size & Forecast

8.3. UK Idiopathic Pulmonary Fibrosis Product Sales Forecast

8.4. UK Idiopathic Pulmonary Fibrosis Market Share Analysis

9. Europe Idiopathic Pulmonary Fibrosis Market Insights

9.1. Europe Idiopathic Pulmonary Fibrosis Market Size & Forecast

9.2. Europe Idiopathic Pulmonary Fibrosis Product Sales Forecast

9.3. Europe Idiopathic Pulmonary Fibrosis Market Share Analysis

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/d278cm/europe_idiopathic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181115005938/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Respiratory Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/15/2018 02:05 PM/DISC: 11/15/2018 02:05 PM

http://www.businesswire.com/news/home/20181115005938/en

AP RADIO
Update hourly